Pioglitazone (AD-4833) ameliorates insulin resistance in patients with NIDDM. AD-4833 Glucose Clamp Study Group, Japan. - Yamasaki,Y.; Kawamori,R.; Wasada,T.; Sato,A.; Omori,Y.; Eguchi,H.; Tominaga,M.; Sasaki,H.; Ikeda,M.; Kubota,M.; Ishida,Y.; Hozumi,T.; et al. (Tohoku J Exp Med, 1997)